Advancing Innovative Immune-Oncology Technologies

Xenetic Biosciences is a biopharmaceutical company focused on advancing proprietary technology platforms across multiple high-value cancer indications.

More About Us

Combating Disease Through Innovative Therapies

Product Pipeline

Platforms

DNase

Oncology platform aimed at improving immunotherapies by targeting Neutrophil Extracellular Traps (NETs)

DNase Platform

Personalized CAR T platform targeting cancers with a patient- and tumor-specific approach.

XCART Platform

Transformative Technologies

Our proprietary and patented technologies are being utilized to create life-changing therapies.

Our Novel Technologies

Stock InformationView Detailed Stock Information

Nasdaq: XBIO Xenetic Biosciences, Inc.
Price
Change
Volume
Day Range
52 Week Range
Investors Presentation

Get Email Alerts

Stay informed about our latest news and updates

Sign up Today